Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes. - Wikidata - awgldk - TriplyDB

Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes.

Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes.

http://www.wikidata.org/entity/Q34982799

about

Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis "Eat me" imaging and therapy Perspectives and opportunities for nanomedicine in the management of atherosclerosis.Calcific aortic valve stenosis: methods, models, and mechanisms Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.Oxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics.Manganese G8 dendrimers targeted to oxidation-specific epitopes: in vivo MR imaging of atherosclerosis.Imaging of Oxidation-Specific Epitopes in Atherosclerosis and Macrophage-Rich Vulnerable Plaques.Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions Iron oxide nanoparticle-micelles (ION-micelles) for sensitive (molecular) magnetic particle imaging and magnetic resonance imaging.Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish.OxLDL-targeted iron oxide nanoparticles for in vivo MRI detection of perivascular carotid collar induced atherosclerotic lesions in ApoE-deficient mice In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions Multimodal iron oxide nanoparticles for hybrid biomedical imaging.Gadolinium-Functionalized Peptide Amphiphile Micelles for Multimodal Imaging of Atherosclerotic Lesions.Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease.Applications and potential toxicity of magnetic iron oxide nanoparticles.Imaging subclinical atherosclerosis: is it ready for prime time? A review.Nanoparticle-based imaging of inflammatory bowel disease.Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI.Detection and treatment of atherosclerosis using nanoparticles.LOX-1-Targeted Iron Oxide Nanoparticles Detect Early Diabetic Nephropathy in db/db Mice.Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome.Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression.Molecular MRI of Inflammation in Atherosclerosis.Macrophage-specific RNA interference targeting via "click", mannosylated polymeric micelles.Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.Multimodality Imaging of Angiogenesis in a Rabbit Atherosclerotic Model by GEBP11 Peptide Targeted Nanoparticles.PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis.Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin α4β1.

P2860

Q26822962-20F4D3BE-4792-4E78-A8F4-0AB23EDBE97C Q28394148-4FEA332C-96B5-4B15-8D83-F3F53F8D2B31 Q30455490-1B0A18E8-C11A-4DF7-AFFD-AFD7B72F6D94 Q30503246-1F5E5B6D-6BE9-4B8F-8B86-52B4EDC04325 Q33839384-0A830436-A305-42F5-ADD8-74A8C7905AE9 Q33857831-B0B1CE2E-06A8-402F-899A-8457431415FC Q34161103-7233BC4B-C8EF-43D6-A003-7273524302F8 Q34477436-B127DB72-63F3-40E1-8147-0A7ADE7A7CF6 Q34518372-893510A1-12F0-4EA1-8F6B-B854A0F3CB36 Q34600428-A4D66535-FE71-4DDA-B787-3E004FB8028E Q34880268-B2ECD78E-924C-4B5A-8677-AD2C65E92C22 Q35578606-7F4F411E-E9F7-4A45-9C60-8C8D8C730681 Q35897012-2BABD0C2-2ADD-4BB9-8E7E-11930BCFBE55 Q35905632-24FF9A68-2FB1-42E7-87BA-C62B81158978 Q36289257-846E3989-6F16-4AE4-AC69-FE84B426E500 Q36387263-469925CA-7AEA-457F-A18E-39391B6C7764 Q36545276-171028BF-75C4-438A-A573-A2D611A506F8 Q37460147-56B1E6D2-1BFD-499F-99A6-A631B2CA30F7 Q38041505-70901A8D-6753-407B-84F7-AA0B511BAC88 Q38047272-50F0F7DE-A59B-4FF0-8245-6247B01CBD8A Q38239604-471AA04F-BF71-47A8-8D95-3232B1E382DE Q38587041-E2C12307-C864-4C40-8813-6C6D43BBD169 Q38815957-05A6A886-3BA5-49E2-BCCD-5BA3D86422EC Q38848673-602D1A5F-F36F-4F67-8204-81396D129C38 Q38911361-FFC969CC-6537-48BB-9433-EF9F5CD2DE5D Q39068959-FDCB873C-559E-47DD-98F4-7CA68CBE163D Q39601696-67D66D3B-FB85-47BD-845F-2A4262C533E7 Q40509301-EC2B3190-DC4A-4599-AA23-7FA58B8DE99B Q41240553-E0F05EE3-E0E8-48B7-BF64-84628B5C94F7 Q42076960-9C17F561-3F6C-464A-8DBF-B79C0BA816F2 Q47138021-8DF2D356-E1B3-44E9-B9BC-79BA4B21E512 Q49955253-B1E1C658-00DF-4555-9CFD-5351F8291AEB Q50355298-B404E843-7400-4782-9140-9351DB3A74EB

P2860

Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes.

http://www.wikidata.org/entity/Q34982799

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Targeted iron oxide particles ...... o oxidation-specific epitopes.

@ast

Targeted iron oxide particles ...... o oxidation-specific epitopes.

@en

Targeted iron oxide particles ...... o oxidation-specific epitopes.

@nl

type

label

Targeted iron oxide particles ...... o oxidation-specific epitopes.

@ast

Targeted iron oxide particles ...... o oxidation-specific epitopes.

@en

Targeted iron oxide particles ...... o oxidation-specific epitopes.

@nl

prefLabel

Targeted iron oxide particles ...... o oxidation-specific epitopes.

@ast

Targeted iron oxide particles ...... o oxidation-specific epitopes.

@en

Targeted iron oxide particles ...... o oxidation-specific epitopes.

@nl

P1433

Q34982799-F777B5CB-930A-4DD7-90D9-006EF8E42F67

P1476

Q34982799-F4951B7B-66B9-4A2C-87A3-6DD264F9BB40

P2093

Q34982799-1CC3A10C-FEA4-4E76-BF02-47F1C8AAE389

Q34982799-29CE281A-09CC-49DA-98FF-382592171836

Q34982799-37E6EB14-69A8-4369-9E18-FB7A4C6C7D12

Q34982799-82F105A9-2608-4655-88C5-1A8BD28358AF

Q34982799-A49F890E-6925-4866-B494-F4B47B45CDFE

Q34982799-ADDA7703-C33D-4AD7-AA5F-E4FF6D7E5F16

Q34982799-C099EDF3-B4D2-45B6-825B-1792848A9E06

Q34982799-F018BF5A-ED90-4D2C-B458-125302F93130

P2860

Q34982799-0981A884-13BD-4A33-9CED-EB3DECBE0406

Q34982799-1C14EEF0-2EBB-45BC-ADB6-6DFAFBD3D494

Q34982799-1EF6393B-9D9A-4488-9D85-11D7122E9D2C

Q34982799-425A15E8-3F5F-4488-94C3-8AD07496705D

Q34982799-509181D4-CA96-4A05-A2FF-7FE8FA09D10D

Q34982799-573693D4-32E0-4B47-B72F-FC8CAF20EA48

Q34982799-5807EEE7-B5C7-4D72-8396-8AAB3567B801

Q34982799-6A76CDD3-88CE-463C-B31C-FC8635E49F3F

Q34982799-7215CB88-94C0-4725-A904-0F334A8D33CB

Q34982799-7496CDD6-2779-4245-B066-5C9F9A13CA81

P304

Q34982799-4ED1A7C7-240B-4B47-907D-BCE344408E11

P31

Q34982799-AB638CE7-52E3-49D6-8DE6-0CFEE6B9B755

P356

Q34982799-33BB960E-7185-4F7E-BFB2-A683BB8447FC

P407

Q34982799-5206A707-7301-44AE-BBC2-2DE1D5D15046

P433

Q34982799-C549735B-0D22-4716-91F2-CE192BB29077

P478

Q34982799-BE86E9CE-643D-4294-9834-5B7122103EED

P50

Q34982799-3BE4B049-87F2-4E34-A2A1-3D21B259B2A9

Q34982799-BD68AA6F-29E6-41EC-AD82-90E22243A2E2

P577

Q34982799-4B5CF424-A523-4CC5-AD04-32714874187F

P5875

Q34982799-997BA007-6AF0-4214-B5A1-59D38A88C968

P698

Q34982799-C841412E-D973-45E8-86A0-BB986504138B

P921

Q34982799-722B7554-235E-4EEF-8D77-6EB63B84BB3F

Q34982799-FE0D1996-6A01-4450-9EF5-56CC5FA212FD

P932

Q34982799-4895458E-8E44-49C2-8637-AC2B03EB7535

P356

J.JACC.2010.09.023

P1433

Journal of the American College of Cardiology

P1476

Targeted iron oxide particles ...... to oxidation-specific epitopes

@en

P2093

Ehsan Izadmehr

http://www.w3.org/2001/XMLSchema#string

Karen C Briley-Saebo

http://www.w3.org/2001/XMLSchema#string

Peter X Shaw

http://www.w3.org/2001/XMLSchema#string

Simone Green

http://www.w3.org/2001/XMLSchema#string

Sotirios Tsimikas

http://www.w3.org/2001/XMLSchema#string

Sung Kee Ryu

http://www.w3.org/2001/XMLSchema#string

Young Seok Cho

http://www.w3.org/2001/XMLSchema#string

Zahi A Fayad

http://www.w3.org/2001/XMLSchema#string

P2860

Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease

NC100150 Injection, a preparation of optimized iron oxide nanoparticles for positive-contrast MR angiography.

Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.

Imaging of atherosclerosis using magnetic resonance: state of the art and future directions.

Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease.

Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events.

The role of innate immunity in atherogenesis.

Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes

Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo.

In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression.

P304

337-347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2010.09.023

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Stephen D Dickson

P577

2010-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49634566

http://www.w3.org/2001/XMLSchema#string

P698

21106318

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3095034

http://www.w3.org/2001/XMLSchema#string